Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.